Biocon Limited

NSEI:BIOCON Stock Report

Market Cap: ₹414.6b

Biocon Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Siddharth Mittal

Chief executive officer

₹57.3m

Total compensation

CEO salary percentage100.0%
CEO tenure5yrs
CEO ownership0.07%
Management average tenure2.3yrs
Board average tenure3.1yrs

Recent management updates

Recent updates

Here's What Analysts Are Forecasting For Biocon Limited (NSE:BIOCON) After Its Second-Quarter Results

Nov 02
Here's What Analysts Are Forecasting For Biocon Limited (NSE:BIOCON) After Its Second-Quarter Results

Why Investors Shouldn't Be Surprised By Biocon Limited's (NSE:BIOCON) Low P/E

Nov 01
Why Investors Shouldn't Be Surprised By Biocon Limited's (NSE:BIOCON) Low P/E

Do Biocon's (NSE:BIOCON) Earnings Warrant Your Attention?

Oct 14
Do Biocon's (NSE:BIOCON) Earnings Warrant Your Attention?

These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively

Sep 20
These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively

Biocon Limited's (NSE:BIOCON) Earnings Haven't Escaped The Attention Of Investors

Jun 29
Biocon Limited's (NSE:BIOCON) Earnings Haven't Escaped The Attention Of Investors

Is Biocon (NSE:BIOCON) A Risky Investment?

Jun 11
Is Biocon (NSE:BIOCON) A Risky Investment?

Biocon (NSE:BIOCON) Is Reducing Its Dividend To ₹0.50

Jun 11
Biocon (NSE:BIOCON) Is Reducing Its Dividend To ₹0.50

Biocon's (NSE:BIOCON) Promising Earnings May Rest On Soft Foundations

May 24
Biocon's (NSE:BIOCON) Promising Earnings May Rest On Soft Foundations

Biocon's (NSE:BIOCON) Dividend Is Being Reduced To ₹0.50

May 23
Biocon's (NSE:BIOCON) Dividend Is Being Reduced To ₹0.50

Is Now The Time To Put Biocon (NSE:BIOCON) On Your Watchlist?

Mar 20
Is Now The Time To Put Biocon (NSE:BIOCON) On Your Watchlist?

Biocon Limited Just Beat EPS By 240%: Here's What Analysts Think Will Happen Next

Feb 12
Biocon Limited Just Beat EPS By 240%: Here's What Analysts Think Will Happen Next

Biocon Limited's (NSE:BIOCON) Intrinsic Value Is Potentially 18% Below Its Share Price

Jan 23
Biocon Limited's (NSE:BIOCON) Intrinsic Value Is Potentially 18% Below Its Share Price

Shareholders Should Be Pleased With Biocon Limited's (NSE:BIOCON) Price

Jan 03
Shareholders Should Be Pleased With Biocon Limited's (NSE:BIOCON) Price

CEO Compensation Analysis

How has Siddharth Mittal's remuneration changed compared to Biocon's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹14b

Jun 30 2024n/an/a

₹16b

Mar 31 2024₹57m₹57m

₹10b

Dec 31 2023n/an/a

₹12b

Sep 30 2023n/an/a

₹5b

Jun 30 2023n/an/a

₹4b

Mar 31 2023₹48m₹48m

₹5b

Dec 31 2022n/an/a

₹4b

Sep 30 2022n/an/a

₹6b

Jun 30 2022n/an/a

₹7b

Mar 31 2022₹42m₹42m

₹6b

Dec 31 2021n/an/a

₹7b

Sep 30 2021n/an/a

₹7b

Jun 30 2021n/an/a

₹7b

Mar 31 2021₹43m₹43m

₹7b

Dec 31 2020n/an/a

₹6b

Sep 30 2020n/an/a

₹6b

Jun 30 2020n/an/a

₹7b

Mar 31 2020₹49m₹31m

₹8b

Compensation vs Market: Siddharth's total compensation ($USD672.19K) is about average for companies of similar size in the Indian market ($USD720.32K).

Compensation vs Earnings: Siddharth's compensation has been consistent with company performance over the past year.

CEO

Siddharth Mittal (46 yo)

5yrs

Tenure

₹57,310,000

Compensation

Mr. Siddharth Mittal, BCom, CA, CPA has been CEO and Director of Biocon Limited since December 1, 2019. He has been Managing Director of Biocon Limited since April 01, 2020 and served as its Joint Managing...

Leadership Team

NamePositionTenureCompensationOwnership
Kiran Mazumdar-Shaw
Founder & Executive Chairperson46.1yrs₹38.43m40.49%
₹ 167.9b
Siddharth Mittal
MD, CEO & Director5yrs₹57.31m0.069%
₹ 287.8m
Peter James Bains
Group Chief Executive Officer1.3yrs₹1.91mno data
Mukesh Kamath
Chief Financial Officerless than a yearno datano data
Arun Gupta
Head of Operations1.7yrsno datano data
Atanu Roy
Group Chief Information Officer4.3yrsno datano data
Saurabh Paliwal
Head of Investor Relations2.3yrsno datano data
Mayank Verma
Company Secretary & Compliance Officer5.4yrs₹5.75mno data
Seema Ahuja
Global Head of Communications & Corporate Brandno datano datano data
Maninder Puri
Head of Human Resourcesno datano datano data
Paul Thomas
Chief Commercial Officerno datano datano data
Abhijit Zutshi
Commercial Head of Biocon Global Genericsno datano data0.019%
₹ 77.0m

2.3yrs

Average Tenure

54.5yo

Average Age

Experienced Management: BIOCON's management team is considered experienced (2.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Kiran Mazumdar-Shaw
Founder & Executive Chairperson46.1yrs₹38.43m40.49%
₹ 167.9b
Siddharth Mittal
MD, CEO & Director5yrs₹57.31m0.069%
₹ 287.8m
Ravi Mazumdar
Non-Executive Non-Independent Director24.3yrs₹6.23m0.44%
₹ 1.8b
Bobby Parikh
Independent Non-Executive Director6.4yrs₹7.81mno data
Naina Lal Kidwai
Additional Non-Executive Independent Director2.7yrs₹6.24mno data
Satish Garg
Member of Scientific Advisory Boardno datano datano data
Nicholas Haggar
Independent Director1.1yrs₹5.20mno data
Shashank Joshi
Member of Scientific Advisory Boardno datano datano data
Rekha Menon
Independent Director1.4yrs₹5.70mno data
Eric Mazumdar
Non-Executive Director3.1yrs₹5.57m0.27%
₹ 1.1b
John Petrie
Member of Scientific Advisory Boardno datano datano data
Atul Dhawan
Non-Executive and Independent Directorless than a yearno datano data

3.1yrs

Average Tenure

62.5yo

Average Age

Experienced Board: BIOCON's board of directors are considered experienced (3.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 18:05
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Biocon Limited is covered by 42 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Meeta ShettyAsian Markets Securities Private Limited
Harith AhamedAvendus Spark
Kunal RanderiaAxis Capital Limited